EducationTranslational Lecture Series

Skin Immune Response: Friend or Foe?

JDD Multimedia

Translational Lecture Series

Dr. Jenny Kim will review skin’s important role as an immune organ and what happens when dysregulation occurs.

Learn More

Skin Immune Response: Friend or Foe? - Exploring the Role of Inflammation and Microbes in Acne Pathogenesis

featuring Dr. Jenny Kim

In this edition of the GW Translational Lecture Series, Dr. Jenny Kim reviews the skin’s important role as an immune organ and what happens when dysregulation occurs.

Presenter

  • Jenny Kim, MD, PhD is a Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA and Chief of Dermatology at the Greater Los Angeles Healthcare System Veterans Affairs.

You May Also Like

Journal of Drugs in Dermatology JDD Article About Socioeconomic Disparities in Gentle Skin Care Access for Atopic Dermatitis: Affordability and Pharmacy Deserts. Image is of deeper skin tone patient’s back covered with erythema, red atopic dermatitis.

Socioeconomic Disparities in Gentle Skin Care Access for Atopic Dermatitis: Affordability and Pharmacy Deserts

| Atopic Dermatitis, Featured Articles, Latest News, The Latest | No Comments
Access Inequity in Atopic Dermatitis Care: Are Your Patients Getting Left Behind? Gentle skin care is a foundation of atopic dermatitis (AD) treatment, but what happens when patients can’t afford,…
Journal of Drugs in Dermatology JDD Article About world vitiligo day. The image is from The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a patient with skin of color who has vitiligo on the scalp, face, and forehead. The patient has darker skin tone.

World Vitiligo Day

| Dyspigmentation, Featured Articles, Latest News, Melasma, Skin of Color, The Latest, Vitiligo | No Comments
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
Journal of Drugs in Dermatology JDD Article Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey

Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
Neoadjuvant Hedgehog Inhibitors: Gaining Ground in Mohs for BCC? A recent survey of American College of Mohs Surgery members reveals that 22% of Mohs surgeons are already using hedgehog pathway…

Leave a Reply